News

Filter

Current filters:

Pricing

151 to 160 of 96157 results

High long-term efficacy of LEO Pharma’s Picato in actinic keratosis confirmed

04-09-2014

New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers…

DermatologicalsLEO PharmaPharmaceuticalPicatoResearch

Sepsis-specific therapies are desperately needed but hard to develop, says GlobalData

Sepsis-specific therapies are desperately needed but hard to develop, says GlobalData

04-09-2014

There is an urgent need to develop sepsis-specific therapies, according to research by consulting firm…

Antibiotics and Infectious diseasesGlobalDataPharmaceuticalResearchSepsis

Action urged to capitalize on opportunity as Australian budget tables reveal loss of support

04-09-2014

The release of the Australian federal government’s ‘Science, Research and Innovation Budget Tables’…

AustraliaBiotechnologyFinancialResearch

NICE draft guidance recommends Alexion’s Soliris for very rare life-threatening blood disorder

NICE draft guidance recommends Alexion’s Soliris for very rare life-threatening blood disorder

04-09-2014

A drug to treat a very rare blood disorder affecting around 200 people in England has been recommended…

Alexion PharmaceuticalsBiotechnologyHematologyPricingRare diseasesRegulationSolirisUK

AbbVie links with Calico in up to $1.5 billion effort on drug discovery

AbbVie links with Calico in up to $1.5 billion effort on drug discovery

04-09-2014

US pharma company AbbVie has entered a novel R&D collaboration with recently-formed Calico, intended…

AbbVieBiotechnologycalicoNeurologicalOncologyResearch

Infinity and AbbVie collaborate on duvelisib in deal worth up to $805 million

Infinity and AbbVie collaborate on duvelisib in deal worth up to $805 million

03-09-2014

US drug discovery firm Infinity Pharmaceuticals has entered into a global collaboration with AbbVie to…

AbbVieduvelisibInfinity PharmaceuticalsIPI-145LicensingOncologyPharmaceutical

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

03-09-2014

The European Commission has granted marketing authorization for ViiV Healthcare’s Triumeq (dolutegravir…

Anti-viralsEuropeGlaxoSmithKlinePharmaceuticalRegulationTriumeqViiV Healthcare

151 to 160 of 96157 results

Back to top